Gerald Gartlehner

Univ.-Prof. Dr. Gerald Gartlehner, MPH

Head of Department - Department for Evidence-based Medicine and Evaluation

vCard CV 190 KB | PDF Photo 800 KB | JPG

Projects (Extract Research Database)

Running projects

Nonpharmacological versus Pharmacological Treatments for Major Depressive Disorder: Surveillance Searches for Living Guidelines 2023-24

Duration: 01/07/2023–30/06/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen

Nachhaltige Gesundheitsversorgung im Spannungsfeld zwischen Tradition und Evidenzbasierung

Duration: 13/04/2023–31/03/2025
Principle investigator for the project (University for Continuing Education Krems): Brigitte Piso
Funding: Sonstige

Becoming Equipped to Tackle Epidemics Right (BETTER)

Duration: 01/03/2023–28/02/2026
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: sonstige öffentlich-rechtliche Einrichtungen (Körperschaften, Stiftungen, Fonds)

Pharmacological Treatment of Acute Episodic Migraine Attacks

Duration: 15/02/2023–31/12/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Sonstige

Interpretation of Non-significant Differences

Duration: 01/12/2022–31/01/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner

Nonpharmacological versus Pharmacological Treatments for Major Depressive Disorder: Surveillance Searches for Living Guidelines

Duration: 01/07/2022–30/06/2023
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen

Drug Effectiveness Review Project/Cooperation RTI

Duration: 01/06/2018–30/06/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen

WHO Collaborating Center

Duration: 01/01/2017–31/12/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Sonstige

Completed projects

WO24-Targeted Immune Modulators - Ulcerative Colitis and Crohn Diseases: Systematic Review Update

Duration: 01/07/2022–30/04/2023
Principle investigator for the project (University for Continuing Education Krems): Andreea Dobrescu
Funding: andere internationale Organisationen

Post-Acute Sequelae of SARS CoV-2 infection (RECOVER)

Duration: 01/04/2022–31/10/2022
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Sonstige

European Partnership on Competencies for High Value Cost Conscious Care 2018

Duration: 01/10/2018–31/05/2022
Principle investigator for the project (University for Continuing Education Krems): Irma Klerings
Funding: EU
Program: ERASMUS+

Pharmacological Versus Non-Pharmacological Interventions for the Treatment of Major Depressive Disorder

Duration: 10/06/2020–31/03/2022
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen

Systematischer Review Point of Care Ultrasound

Duration: 11/10/2018–31/03/2021
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: andere internationale Organisationen

DIMDI - Erstellung von HTA-Projekten

Duration: 01/12/2013–11/12/2019
Principle investigator for the project (University for Continuing Education Krems): Anna Glechner
Funding: Sonstige
Program: ---

Rapid Reviews - Single Screening RCT classifier

Duration: 01/12/2018–31/10/2019
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: Private (Stiftungen, Vereine etc.)

Rapid Review-Single Screening

Duration: 01/10/2018–30/09/2019
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Program: ---

Surgery or embolization for varicoceles in subfertile men

Duration: 01/09/2018–01/09/2019
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Funding: CDG
Program: ---

Case study of a single-human, machine-assisted abstract screening approach

Duration: 01/01/2019–31/05/2019
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner
Program: ---

Load more
from

Publications (Extract Research Database)

Affengruber, L.; Wagner, G.; Dobrescu, A.; Toromanova, A.; Chapman, A.; Persad, E.; Klerings, I.; Gartlehner, G. (2023). Values and Preferences of Patients With Depressive Disorders Regarding Pharmacologic and Nonpharmacologic Treatments. A Rapid Review. Annals of Internal Medicine, 176(2): 217-223.

Dobrescu, A.; Chapman, A.; Affengruber, L.; Persad, E.; Toromanova, A.; Wagner, G.; Klerings, I.; Emprechtinger, R.; Gartlehner, G. (2023). Cost-Effectiveness of First- and Second-Step Treatment Strategies for Major Depressive Disorder. A Rapid Review. Annals of Internal Medicine, 176(2): 212-216

Gartlehner, G.; Dobrescu, A.; Chapman, A.; Toromanova, A.; Emprechtinger, R.; Persad, E.; Affengruber, L.; Pieh, C.; Klerings, I.; Wagner, G. (2023). Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder. A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians. Annals of Internal Medicine, 176: 196-211

Gartlehner, G.; Kahwati, L. (2023). Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons—Reply. JAMA, 329(11): 943

Gartlehner, G.; Nussbaumer-Streit, B.; Devane, D.; Kahwati, L.; Viswanathan, M.; King, V.J.; Qaseem, A.; Akl, E.; Schuenemann, H.J. (2023). Rapid reviews methods series: Guidance on assessing the certainty of evidence. BMJ Evidence-Based Medicine, epub: 1-5

Gartlehner, G.; Persad, E.; Ledinger, D.; Chapman, A.; Gadinger, A.; Feyertag, J.; Emprechtinger, R. (2023). Beyond statistical significance: nuanced interpretations of statistically nonsignificant results were rare in Cochrane reviews – a metaepidemiological study. Journal of Clinical Epidemiology, 160: 46-53

Gartlehner, G.; Schernhammer, E.; Lax, S.F.; Preusser, M.; Bachler, H.; Tietzer, H.; Kletecka-Pulker, M.; Turnher, H.; Siebert, U. (2023). Screening for colorectal cancer. Wiener klinische Wochenschrift, 2023: 1-9

Glechner, A.; Wagner, G.; Mitus, J.W.; Teufer, B.; Klerings, I.; Böck, N.; Grillich, L.; Berzaczy, D.; Helbich, T.H.; Gartlehner, G.; (2023). Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database of Systematic Reviews, 3: 1-78

Harlfinger, J.; Sommer, I.; Gartlehner, G. (2023). [WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention (Second Edition)]. Gesundheitswesen, Vol. 85, Issue 7: 630-634

Klerings, I.; Robalino, S.; Booth, A.; Escobar-Liquitay, C.M.; Sommer, I.; Gartlehner, G.; Devane, D.; Waffenschmidt, S.; (2023). Rapid reviews methods series: Guidance on literature search. BMJ Evidence-Based Medicine, epub: 1-6

Moick, S.; Sommer, I.; Gartlehner, G. (2023). WHO Guideline for the Pharmacological Treatment of Hypertension in Adults. Gesundheitswesen, 85(2): 139-142

Nussbaumer-Streit, B.; Sommer, I.; Hamel, C.; Devane, D.; Noel-Storr, A.; Puljak, L.; Trivella, M.; Gartlehner, G.; (2023). Rapid reviews methods series: Guidance on team considerations, study selection, data extraction and risk of bias assessment. BMJ Evidence-Based Medicine, epub: 1-6

Affengruber, L.; Dobrescu, A.; Persad, E.; Klerings, I.; Wagner, G.; Sommer, I.; Gartlehner, G. (2022). Characteristics and recovery methods of studies falsely excluded during literature screening-a systematic review. Systematic Reviews, 11: 236

Dobrescu, A.I.; Ebenberger, A.; Harlfinger, J.; Griebler, U.; Klerings, I.; Nussbaumer-Streit, B.; Chapman, A.; Affengruber, L.; Gartlehner, G. (2022). Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure - A systematic review. Science of The Total Environment, Volume 806, Part 1: https://doi.org/10.1016/j.scitotenv.2021.150480

Ewald, H.; Klerings, I.; Wagner, G.; Heise, T.L.; Stratil, J.M.; Lhachimi, S.K.; Hemkens, L.G.; Gartlehner, G.; Armijo-Olivo, S.; Nussbaumer-Streit, B. (2022). Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study. Journal of Clinical Epidemiology, 149: 154-164

Gartlehner, G.; Emprechtinger, R.; Hackl, M.; Jutz, F.L.; Gartlehner, J.E.; Nonninger, J.N.; Klerings, I.; Dobrescu, A.I. (2022). Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis. BMJ Evidence-Based Medicine, Published Online First: 15 March 2022.: doi: 10.1136/bmjebm-2021-111846

Gartlehner, G.; Patel, S.V.; Reddy, S.; Rains, C.; Schwimmer, M.; Kahwati, L. (2022). Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 328(17): 1747-1765

Harlfinger, J.; Nussbaumer-Streit, B.; Gartlehner, G. (2022). Prävention der Mutter-zu-Kind-Übertragung des Hepatitis-B-Virus: Leitlinie zur antiviralen Prophylaxe während der Schwangerschaft. Gesundheitswesen, efirst: 1-5

Noel-Storr, A.; Gartlehner, G.; Dooley, G.; Persad, E.; Nussbaumer-Streit, B. (2022). Crowdsourcing the identification of studies for COVID-19-related Cochrane Rapid Reviews. Research Synthesis Methods, -: 1-10

Nußbaumer-Streit, B.; Jesser, A.; Humer, E.; Barke, A.; Doering, B.K.; Haid, B.; Schimböck, W.; Reisinger, A.; Gasser, M.; Eichberger-Heckmann, H.; Stippl, P.; Gartlehner, G.; Pieh, C.; Probst, T. (2022). A web-survey assessed attitudes toward evidence-based practice among psychotherapists in Austria. Scientific Reports, 12: 9374

Load more
from

Lectures (Extract Research Database)

Automated Data Extraction from Journal Articles Using a Large Language Model

Fall Data Science Lunch and Learns, 12/09/2023

How to do a rapid review – updated methods guidance

Cochrane Colloquium, 05/09/2023

Rating the Certainty of Evidence. Workshop on Cost Conscious Care.

European Association of Neurology, 30/06/2023

Podiumsdiskussion: Von der Idee zur Innovation – Gesundheitsdienstleistungen von morgen

ApoKongress, 16/06/2023

GRADE’s Integration of Values and Preferences in Guideline Development.

18th Biennial European Conference of the Society of Medical Decision Making, 22/05/2023

Pharmacological interventions for the management of children and adolescents living with obesity – an update of a Cochrane systematic review with meta-analyses

30th European Congress on Obesity, 17/05/2023

Navigating New Normals: The Pandemic's Lessons on Healthcare and Sustainability

Illinois in Vienna Programs. Wirtschaftuniversität Wien, 11/05/2023

Targeted Immune Modulators for Ulcerative Colitis and Crohn’s Disease

DERP Governance Call, 06/04/2023

COVID Behandlungen im niedergelassenen Bereich

Seminare im März der Ärztekammer für Steiermark, 29/03/2023

Methoden und Evidenzbasis für Empfehlungen des Nationalen Screeningkomitees (NSK) zum Darmkrebs-Screening.

Informationsveranstaltung Gesundheit Österreich GmbH, 12/01/2023

Load more
from

Tags